So, task one talks about encrypted patient identifiers. This makes it sound like they're not going after patients, but are targetting pharmaceutical companies a

So, task one talks about encrypted patient identifiers. This makes it sound like they're not going after patients, but are targetting pharmaceutical companies and doctors. Task 1: Provide and maintain data on a minimum of 85 percent of all prescriptions for Schedule/Class II through V prescription drugs (additional non-controlled items may be requested for possible scheduling actions) written and/or filled in the United States and trust territories: a) Prescription data shall include, but is not limited to: • The number of prescriptions filled, • The number of new prescriptions filled, • The number of refills filled, by date filled, • The name of the controlled substance • The days’ supply for the patient (e.g. 5 days, 15 days, et.), • The prescribers name and DEA registration number, and specialty • An encrypted patient identifier to whom the prescription was written • Date prescription was dispensed • Payment Type: cash, government payer, commercial payer • Dosing information: quantity and days’ sup --- Here's the patient information they want: > Patients • Number of instances of more than one Schedule II prescription for the same drug, and written within three days of each other by different prescribers • Number of instances of more than one Schedule II prescriptions for the same drug and written within three days of each other by the same prescriber • Number of instances of more than two patients, with the same address, receive the same drug in the same quantity from the same doctor on the same day. • Number of early refills Opiate and Benzo combine • Number of early Schedule II • Distance between patient and pharmacy • Average distance between patient and pharmacy for a combination of Opiate, Benzo and a muscle relaxer. • Distance between patient and pharmacy for Schedule II • Distance between patient and prescriber • Distance between patient and prescriber for Schedule II • Number of Opiate and Buprenorphine combinations • Number of Paid “cash” Schedule II • Number of Oxycodone 30 MG and 15 MG within five days overlap • Number of times Opioid Cough Syrup exceeds 90 day supply • Number of Oxycodone 30 MG and Hydromorphone 8 MG within five days overlap • Average MME Per Day • Average Total MME per pharmacy visit • Number of Opiate and Benzo combine within 3 days • Number of Opiate and Benzo prescriptions for the same person on the same filled day at different pharmacies. • Number of Opiate and Benzo prescriptions filled for the same person on the same day from different prescribers • Number of Opiate and Benzo prescriptions written on the same day to the same person by different prescribers • Number of Opiate and Benzo filled on the same person on the same day • Number of Opiate and Benzo filled for the same person on the same day at the same pharmacy They also say this: > f) Fully HIPAA-compliant. > Current pharmacy and prescription data updated on a daily basis. > Task 2: Streamline process for requesting the unmasking of pharmacy information. (PII shall be withheld or redacted unless specifically requested by subpoena.)